Related references
Note: Only part of the references are listed.Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Weilong Shang et al.
NPJ VACCINES (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
Coronavirus vaccines: key questions
Ewen Callaway
NATURE (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
Lu Lu et al.
MICROBES AND INFECTION (2013)
Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients
Lifeng Liu et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2011)
Disappearance of antibodies to SARS-associated coronavirus after recovery
Wu-Chun Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals
LQ Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Management and prevention of SARS in china
NS Zhong
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2004)
Share Paper
